Literature DB >> 27708279

Hypertension: Lower or higher blood-pressure targets for high-risk patients?

Alberto Zanchetti1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27708279     DOI： 10.1038/nrcardio.2016.165

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  9 in total

Review 1.  Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels - updated overview and meta-analyses of randomized trials.

Authors:  Costas Thomopoulos; Gianfranco Parati; Alberto Zanchetti
Journal:  J Hypertens       Date:  2016-04       Impact factor: 4.844

Review 2.  Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials.

Authors:  Costas Thomopoulos; Gianfranco Parati; Alberto Zanchetti
Journal:  J Hypertens       Date:  2014-12       Impact factor: 4.844

3.  Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study.

Authors:  Emmanuelle Vidal-Petiot; Ian Ford; Nicola Greenlaw; Roberto Ferrari; Kim M Fox; Jean-Claude Tardif; Michal Tendera; Luigi Tavazzi; Deepak L Bhatt; Philippe Gabriel Steg
Journal:  Lancet       Date:  2016-08-30       Impact factor: 79.321

4.  2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).

Authors:  Paul A James; Suzanne Oparil; Barry L Carter; William C Cushman; Cheryl Dennison-Himmelfarb; Joel Handler; Daniel T Lackland; Michael L LeFevre; Thomas D MacKenzie; Olugbenga Ogedegbe; Sidney C Smith; Laura P Svetkey; Sandra J Taler; Raymond R Townsend; Jackson T Wright; Andrew S Narva; Eduardo Ortiz
Journal:  JAMA       Date:  2014-02-05       Impact factor: 56.272

5.  Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Authors:  William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

6.  When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal.

Authors:  Alberto Zanchetti; Guido Grassi; Giuseppe Mancia
Journal:  J Hypertens       Date:  2009-05       Impact factor: 4.844

7.  2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redón; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad
Journal:  J Hypertens       Date:  2013-07       Impact factor: 4.844

8.  Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial.

Authors:  O R Benavente; C S Coffey; R Conwit; R G Hart; L A McClure; L A Pearce; P E Pergola; J M Szychowski
Journal:  Lancet       Date:  2013-05-29       Impact factor: 79.321

9.  Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial.

Authors:  Alberto Zanchetti; Lisheng Liu; Giuseppe Mancia; Gianfranco Parati; Guido Grassi; Marco Stramba-Badiale; Vincenzo Silani; Grzegorz Bilo; Giovanni Corrao; Antonella Zambon; Lorenza Scotti; Xinhua Zhang; HayYan Wang; Yuqing Zhang; Xuezhong Zhang; Ting Rui Guan; Eivind Berge; Josep Redon; Krzysztof Narkiewicz; Anna Dominiczak; Peter Nilsson; Margus Viigimaa; Stéphane Laurent; Enrico Agabiti-Rosei; Zhaosu Wu; Dingliang Zhu; José Luis Rodicio; Luis Miguel Ruilope; Nieves Martell-Claros; Fernando Pinto; Roland E Schmieder; Michel Burnier; Maciej Banach; Renata Cifkova; Csaba Farsang; Alexandra Konradi; Irina Lazareva; Yuriy Sirenko; Maria Dorobantu; Arman Postadzhiyan; Rok Accetto; Bojan Jelakovic; Dragan Lovic; Athanasios J Manolis; Philippos Stylianou; Serap Erdine; Dror Dicker; Gangzhi Wei; Chengbin Xu; Hengge Xie; Antonio Coca; John O'Brien; Gary Ford
Journal:  J Hypertens       Date:  2014-09       Impact factor: 4.844
  9 in total
  3 in total

1.  Novel Antihypertensive Peptides Derived from Chicken Foot Proteins.

Authors:  Francisca I Bravo; Anna Mas-Capdevila; Maria Margalef; Anna Arola-Arnal; Begoña Muguerza
Journal:  Mol Nutr Food Res       Date:  2019-04-10       Impact factor: 5.914

Review 2.  Effect of Hesperidin on Cardiovascular Disease Risk Factors: The Role of Intestinal Microbiota on Hesperidin Bioavailability.

Authors:  Anna Mas-Capdevila; Joan Teichenne; Cristina Domenech-Coca; Antoni Caimari; Josep M Del Bas; Xavier Escoté; Anna Crescenti
Journal:  Nutrients       Date:  2020-05-20       Impact factor: 5.717

3.  ACE Inhibitory and Antihypertensive Activities of Wine Lees and Relationship among Bioactivity and Phenolic Profile.

Authors:  Raúl López-Fernández-Sobrino; Jorge R Soliz-Rueda; Maria Margalef; Anna Arola-Arnal; Manuel Suárez; Francisca I Bravo; Begoña Muguerza
Journal:  Nutrients       Date:  2021-02-20       Impact factor: 5.717
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.